A phase II, randomised trial of Azixa in combination with temozolomide in patients with metastatic melanoma.
Phase of Trial: Phase II
Latest Information Update: 23 Jun 2014
At a glance
- Drugs Temozolomide; Verubulin
- Indications Cancer metastases; Malignant melanoma
- Focus Therapeutic Use
- 23 Jun 2014 Planned number of patients changed to 450.
- 23 Jun 2014 Planned number of patients changed from 450 to NULL.
- 10 Nov 2010 Status changed from recruiting to completed, according to an EpiCept media release.